EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	19.53M -81.8%
Revenue (ttm)	46.28M -36.4%
Net Income	-5.32M
EPS	-0.11
Shares Out	47.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.04 (9.76%)
Ex-Dividend Date	Nov 24, 2025

Volume	12,141
Open	0.4050
Previous Close	0.4150
Day's Range	0.3970 - 0.4100
52-Week Range	0.3550 - 3.3800
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its pr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error